Morphine Sulfate

Product NDC: 76045-008
11-digit product format: 760450008
Labeler code: 76045
Product ID: 76045-008_e61f6eb4-cc71-47d3-b2f6-5e689c773779
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Morphine Sulfate
Dosage form: INJECTION, SOLUTION
Route: INTRAMUSCULAR; INTRAVENOUS
Labeler: Fresenius Kabi, USA LLC
Application: NDA204223
Marketing category: NDA
Marketing start: 2013-10-30
Substance: MORPHINE SULFATE
Active strength: 10 mg/mL
Pharmacologic classes: Full Opioid Agonists [MoA], Opioid Agonist [EPC]
DEA schedule: CII
NDC exclude flag: No
Listing certified through: 2027-12-31
Current FDA listing: Yes

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	76045-008		D	Discontinued by firm	2026-10-05
excluded package	package	76045-008	76045-008-10	D	Discontinued by firm	2026-10-05
excluded package	package	76045-008	76045-008-11	D	Discontinued by firm	2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 3 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Product NDC	Package NDC	Code	Status	Archive	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	76045-008	76045-008-11	D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	76045-008	76045-008-10	D	Discontinued by firm	excluded / ndc_excluded.zip	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	76045-008	76045-008-11	D	Discontinued by firm	excluded / ndc_excluded.zip	`f5e01cc5f278…`	`a2eaf40c39c3…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	RLD / RS	Approval date
N204223-001	MORPHINE SULFATE	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30
N204223-002	MORPHINE SULFATE	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30
N204223-003	MORPHINE SULFATE	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30
N204223-004	MORPHINE SULFATE	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30
N204223-005	MORPHINE SULFATE	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30

Orange Book patents#

Current patent rows page 1 of 1 · 20 matching rows.

Application-product, Patent, Expiration table
Application-product	Patent	Expiration	Use code	Coverage / status	Submission date
N204223-001	9072781	2034-03-12		Drug product	2015-07-13
N204223-001	9192608	2034-03-12	U-43		2015-12-04
N204223-001	9192608	2034-03-12	U-55		2015-12-04
N204223-001	9248229	2034-03-12		Drug product	2016-02-17
N204223-002	9072781	2034-03-12		Drug product	2015-07-13
N204223-002	9192608	2034-03-12	U-43		2015-12-04
N204223-002	9192608	2034-03-12	U-55		2015-12-04
N204223-002	9248229	2034-03-12		Drug product	2016-02-17
N204223-003	9072781	2034-03-12		Drug product	2015-07-13
N204223-003	9192608	2034-03-12	U-43		2015-12-04
N204223-003	9192608	2034-03-12	U-55		2015-12-04
N204223-003	9248229	2034-03-12		Drug product	2016-02-17
N204223-004	9072781	2034-03-12		Drug product	2015-07-13
N204223-004	9192608	2034-03-12	U-43		2015-12-04
N204223-004	9192608	2034-03-12	U-55		2015-12-04
N204223-004	9248229	2034-03-12		Drug product	2016-02-17
N204223-005	9072781	2034-03-12		Drug product	2015-07-13
N204223-005	9192608	2034-03-12	U-43		2015-12-04
N204223-005	9192608	2034-03-12	U-55		2015-12-04
N204223-005	9248229	2034-03-12		Drug product	2016-02-17

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 6 · 215 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204223-001	MORPHINE SULFATE	2MG/ML (2MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204223-002	MORPHINE SULFATE	4MG/ML (4MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204223-003	MORPHINE SULFATE	5MG/ML (5MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204223-004	MORPHINE SULFATE	8MG/ML (8MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD	2013-10-30	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N204223-005	MORPHINE SULFATE	10MG/ML (10MG/ML)	SOLUTION / INTRAMUSCULAR, INTRAVENOUS	RLD, RS	2013-10-30	`03ed91905a0d…`

Observed Orange Book patent history#

Patent history page 1 of 22 · 860 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Patent	Expiration	Use code	Coverage / status	Submission date	Source SHA-256
2026-09-14 22:38:34	2026-08	N204223-001	9072781	2034-03-12		Drug product	2015-07-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-001	9192608	2034-03-12	U-43		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-001	9192608	2034-03-12	U-55		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-001	9248229	2034-03-12		Drug product	2016-02-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-002	9072781	2034-03-12		Drug product	2015-07-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-002	9192608	2034-03-12	U-43		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-002	9192608	2034-03-12	U-55		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-002	9248229	2034-03-12		Drug product	2016-02-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-003	9072781	2034-03-12		Drug product	2015-07-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-003	9192608	2034-03-12	U-55		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-003	9192608	2034-03-12	U-43		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-003	9248229	2034-03-12		Drug product	2016-02-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-004	9072781	2034-03-12		Drug product	2015-07-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-004	9192608	2034-03-12	U-43		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-004	9192608	2034-03-12	U-55		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-004	9248229	2034-03-12		Drug product	2016-02-17	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-005	9072781	2034-03-12		Drug product	2015-07-13	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-005	9192608	2034-03-12	U-55		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-005	9192608	2034-03-12	U-43		2015-12-04	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N204223-005	9248229	2034-03-12		Drug product	2016-02-17	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N204223-001	9072781	2034-03-12		Drug product	2015-07-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-001	9192608	2034-03-12	U-43		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-001	9192608	2034-03-12	U-55		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-001	9248229	2034-03-12		Drug product	2016-02-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-002	9072781	2034-03-12		Drug product	2015-07-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-002	9192608	2034-03-12	U-43		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-002	9192608	2034-03-12	U-55		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-002	9248229	2034-03-12		Drug product	2016-02-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-003	9072781	2034-03-12		Drug product	2015-07-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-003	9192608	2034-03-12	U-55		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-003	9192608	2034-03-12	U-43		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-003	9248229	2034-03-12		Drug product	2016-02-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-004	9072781	2034-03-12		Drug product	2015-07-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-004	9192608	2034-03-12	U-43		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-004	9192608	2034-03-12	U-55		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-004	9248229	2034-03-12		Drug product	2016-02-17	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-005	9072781	2034-03-12		Drug product	2015-07-13	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-005	9192608	2034-03-12	U-55		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-005	9192608	2034-03-12	U-43		2015-12-04	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N204223-005	9248229	2034-03-12		Drug product	2016-02-17	`caaa826d4ba7…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product: Yes
Brand name base: Morphine Sulfate
Listing expiration: 2027-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
MORPHINE SULFATE	10 mg/mL

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
X3P646A2J0	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 6 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
894912	Internal RxNorm lookup
894914	Internal RxNorm lookup
998212	Internal RxNorm lookup
998213	Internal RxNorm lookup
1442790	Internal RxNorm lookup
2752697	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
1f53de80-efc8-4930-b3e3-fba0d026af05	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
89941d4c-522d-cee0-b273-43cfa7ef6d35	Product name	4	20250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2	Product name	5	20250304
f15f9e76-db42-8a50-218a-5ef5affa58da	Product name	4	20240216
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
944b0689-73f4-6a2f-c654-1180896353c0	Product name	4	20220210
f1e0dc7e-7d61-4625-b6d9-4894927679d7	Product name	2	20211025
e4870509-7e28-6f92-f0be-dd3dd889a9cf	Product name	5	20200810
6e9d4a47-c464-b93e-aebc-ad7bffc9c4cd	Product name	2	20190619
444b3e50-f226-46ef-bfca-2e7035d140cd	Product name	1	20190611
816b97af-edc5-4060-aff1-b814bdbcad50	Product name	1	20190415
67e166c6-23d4-4709-b77d-5ca6182dcae0	Product name	1	20180830
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
c573a64c-fe17-2eac-fbcb-788868b4ff6b	Product name	9	20180619
419aab54-5d5a-4146-9453-026d4a9991be	Product name	2	20170525
7c1819cf-69a0-41dc-aeaa-a820729bc959	Product name	1	20170406
7a68fc31-10e5-df04-67e0-3a613a2d4d2e	Product name	5	20161114
175682a8-c657-45a2-9dfb-c565306b03c8	Product name	1	20160112
b73dadd0-1b4a-4f88-956f-a2be216c8fad	Product name	1	20151123
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
89dac932-b90a-4410-9ab1-84c53e57de25	Product name	1	20150316
4c272b1c-87fc-ebc0-994d-ac28b1e0416e	Product name	1	20140508
5668b646-cd56-c3c7-bdea-3f6b1a8840db	Product name	1	20140508
684ea482-2e8b-14af-5664-b98f1e402036	Product name	1	20140508
7a537f54-d322-5e54-a3a2-035d3e21c3c6	Product name	1	20140508
810ab97e-f109-f41c-7c83-6a652a9cbf43	Product name	1	20140508
87711080-88eb-65c5-b2dd-bf99e700a372	Product name	1	20140508
8dbefedf-0a0d-a224-5a3c-66dc9e11c2dd	Product name	1	20140508
b060cc1a-fe47-856b-0b77-4448b5963de8	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508
ec2149b3-5c6d-5344-f757-c86411073075	Product name	1	20140508
ed912195-5da0-0f2f-6f4b-3ef17710cbe3	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
76045-008-01	Morphine Sulfate	1 mL in 1 SYRINGE, GLASS	INJECTION, SOLUTION	1		7
76045-008-11	Morphine Sulfate	10 in 1 CARTON	INJECTION, SOLUTION	10		7

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
76045-008-10	ML - Milliliter	76045-008	1a6160d0-a1a9-4a01-a50d-6f650a232b18	1	2014-05-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Morphine Sulfate	ACTIVE INGREDIENT	X3P646A2J0	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5
Morphine	ACTIVE MOIETY	76I7G6D29C	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5
Calcium Chloride	INACTIVE INGREDIENT	M4I0D6VV5M	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5
Citric Acid Monohydrate	INACTIVE INGREDIENT	2968PHW8QP	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5
Edetate Disodium	INACTIVE INGREDIENT	7FLD91C86K	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5
Sodium chloride	INACTIVE INGREDIENT	451W47IQ8X	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5
Trisodium Citrate Dihydrate	INACTIVE INGREDIENT	B22547B95K	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5
Water	INACTIVE INGREDIENT	059QF0KO0R	MORPHINE SULFATE INJECTION, SOLUTION [BD RX INC.]	5

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
76045-008	MORPHINE SULFATE (MORPHINE SULFATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC ]	17	Current NDC, Legacy NDC	20210310_b62ee1ef-db55-417a-a02e-b103890f9c4b.zip
76045-008	MORPHINE SULFATE INJECTION, SOLUTION [FRESENIUS KABI, USA LLC]	7	Current NDC, Legacy NDC, 2 package rows	20250412_1f53de80-efc8-4930-b3e3-fba0d026af05.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Morphine Sulfate	MORPHINE SULFATE	Fresenius Kabi, USA LLC	1f53de80-efc8-4930-b3e3-fba0d026af05	2026-08-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 204223 application number: NDA204223 ndc (product): 76045-008
Morphine Sulfate	MORPHINE SULFATE	Fresenius Kabi USA, LLC	582f42e5-444e-4246-af8c-e7e28097c69a	2026-07-31	Boxed warning, Warnings, Adverse reactions	Exact identifier application applno (NDA): 204223 application number: NDA204223

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
X3P646A2J0	MORPHINE SULFATE	6211-15-0	MORPHINE SULFATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
894912	morphine sulfate 10 MG in 1 ML Prefilled Syringe	PSN	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998212	morphine sulfate 2 MG in 1 ML Prefilled Syringe	PSN	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998213	morphine sulfate 4 MG in 1 ML Prefilled Syringe	PSN	1f53de80-efc8-4930-b3e3-fba0d026af05	7
1442790	morphine sulfate 5 MG in 1 ML Prefilled Syringe	PSN	1f53de80-efc8-4930-b3e3-fba0d026af05	7
894914	morphine sulfate 8 MG in 1 ML Prefilled Syringe	PSN	1f53de80-efc8-4930-b3e3-fba0d026af05	7
894912	1 ML morphine sulfate 10 MG/ML Prefilled Syringe	SCD	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998212	1 ML morphine sulfate 2 MG/ML Prefilled Syringe	SCD	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998213	1 ML morphine sulfate 4 MG/ML Prefilled Syringe	SCD	1f53de80-efc8-4930-b3e3-fba0d026af05	7
1442790	1 ML morphine sulfate 5 MG/ML Prefilled Syringe	SCD	1f53de80-efc8-4930-b3e3-fba0d026af05	7
894914	1 ML morphine sulfate 8 MG/ML Prefilled Syringe	SCD	1f53de80-efc8-4930-b3e3-fba0d026af05	7
894912	1 ML MS 10 MG/ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998212	1 ML MS 2 MG/ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998213	1 ML MS 4 MG/ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
1442790	1 ML MS 5 MG/ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
894914	1 ML MS 8 MG/ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
894912	morphine sulfate 10 MG per 1 ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998212	morphine sulfate 2 MG per 1 ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
998213	morphine sulfate 4 MG per 1 ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
1442790	morphine sulfate 5 MG per 1 ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7
894914	morphine sulfate 8 MG per 1 ML Prefilled Syringe	SY	1f53de80-efc8-4930-b3e3-fba0d026af05	7

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
76045-008-01	76045000801	1 mL in 1 SYRINGE, GLASS	1 ml					Historical
76045-008-10	76045000810	24 BLISTER PACK in 1 CARTON (76045-008-10) > 1 SYRINGE, GLASS in 1 BLISTER PACK (76045-008-00) > 1 mL in 1 SYRINGE, GLASS	24 blister pack	2013-10-30	0000-00-00	No	No	Current
76045-008-11	76045000811	10 SYRINGE, GLASS in 1 CARTON (76045-008-11) > 1 mL in 1 SYRINGE, GLASS (76045-008-01)		2019-11-25	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Morphine Sulfate	Fresenius Kabi, USA LLC \| Fresenius Kabi USA, LLC	2026-08-31	HUMAN PRESCRIPTION DRUG LABEL	8
Morphine Sulfate	Fresenius Kabi USA, LLC	2025-09-04	HUMAN PRESCRIPTION DRUG LABEL	18